These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24722806)

  • 21. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention.
    Ohno Y; Maekawa Y; Miyata H; Inoue S; Ishikawa S; Sueyoshi K; Noma S; Kawamura A; Kohsaka S; Fukuda K
    J Am Coll Cardiol; 2013 Oct; 62(14):1260-1266. PubMed ID: 23770181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention.
    Demirkol S; Balta S; Akgul EO; Cakar M; Sarlak H; Kurt O
    Clinics (Sao Paulo); 2013 Jul; 68(7):1071. PubMed ID: 23917676
    [No Abstract]   [Full Text] [Related]  

  • 24. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
    Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.
    Watabe H; Sato A; Hoshi T; Takeyasu N; Abe D; Akiyama D; Kakefuda Y; Nishina H; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Jun; 174(1):57-63. PubMed ID: 24726211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.
    Busch SV; Jensen SE; Rosenberg J; Gögenur I
    J Interv Cardiol; 2013 Feb; 26(1):97-105. PubMed ID: 23240788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty.
    Zhao JL; Yang YJ; Zhang YH; You SJ; Wu YJ; Gao RL
    Int J Cardiol; 2008 Jun; 126(3):435-6. PubMed ID: 17462753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet count and volume indices in patients with contrast-induced acute kidney injury and acute myocardial infarction treated invasively.
    Francuz P; Kowalczyk J; Swoboda R; Przybylska-Siedlecka K; Kozieł M; Podolecki T; Świątkowski A; Lenarczyk R; Średniawa B; Kalarus Z
    Kardiol Pol; 2015; 73(7):520-6. PubMed ID: 25761790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.
    Peguero JG; Cornielle V; Gomez SI; Issa OM; Heimowitz TB; Santana O; Goldszer RC; Lamas GA
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):310-4. PubMed ID: 24367008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
    Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Elbasan Z; Şahin DY; Gür M; Kuloğlu O; Kivrak A; Içen YK; Türkoglu C; Yildirim A; Özdogru I; Çayli M
    Angiology; 2014 Jan; 65(1):37-42. PubMed ID: 23109331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-Induced Acute Kidney Injury: An Update.
    Chalikias G; Drosos I; Tziakas DN
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):215-28. PubMed ID: 26780748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience.
    Farhan S; Vogel B; Tentzeris I; Jarai R; Freynhofer MK; Smetana P; Egger F; Kautzky-Willer A; Huber K
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):55-61. PubMed ID: 25722456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
    Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
    Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
    Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.